- Home
- EVAX vs LIQT Comparison
EVAX vs LIQT Comparison
Compare EVAX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- LIQT
- Stock Information
- Founded
- EVAX 2008
- LIQT 2004
- Country
- EVAX Denmark
- LIQT Denmark
- Employees
- EVAX N/A
- LIQT N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- LIQT Industrial Machinery/Components
- Sector
- EVAX Health Care
- LIQT Technology
- Exchange
- EVAX Nasdaq
- LIQT Nasdaq
- Market Cap
- EVAX 16.3M
- LIQT 16.9M
- IPO Year
- EVAX 2021
- LIQT N/A
- Fundamental
- Price
- EVAX $1.69
- LIQT $1.63
- Analyst Decision
- EVAX Strong Buy
- LIQT Strong Buy
- Analyst Count
- EVAX 2
- LIQT 2
- Target Price
- EVAX $10.00
- LIQT $4.60
- AVG Volume (30 Days)
- EVAX 65.8K
- LIQT 6.7K
- Earning Date
- EVAX 05-27-2025
- LIQT 03-28-2025
- Dividend Yield
- EVAX N/A
- LIQT N/A
- EPS Growth
- EVAX N/A
- LIQT N/A
- EPS
- EVAX N/A
- LIQT N/A
- Revenue
- EVAX $3,344,000.00
- LIQT $14,604,618.00
- Revenue This Year
- EVAX $102.45
- LIQT N/A
- Revenue Next Year
- EVAX $200.44
- LIQT $31.19
- P/E Ratio
- EVAX N/A
- LIQT N/A
- Revenue Growth
- EVAX 4480.82
- LIQT N/A
- 52 Week Low
- EVAX $1.61
- LIQT $1.34
- 52 Week High
- EVAX $22.05
- LIQT $3.20
- Technical
- Relative Strength Index (RSI)
- EVAX 36.47
- LIQT 56.73
- Support Level
- EVAX $1.67
- LIQT $1.47
- Resistance Level
- EVAX $1.97
- LIQT $1.65
- Average True Range (ATR)
- EVAX 0.12
- LIQT 0.09
- MACD
- EVAX 0.04
- LIQT 0.03
- Stochastic Oscillator
- EVAX 22.22
- LIQT 69.98
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.